Drug Approval | March 01, 2023
Zydus receives final approval from the USFDA for Apixaban Tablets
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
This artificial RNA ligase has higher thermostability than natural RNA ligase
In a bid to better leverage its clinical expertise and drive quality reporting across its centres, Thyrocare has added SigTuple’s AI100 to automate the microscopic review in its laboratories
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
There is a fast resurgence in the transplant activities post COVID
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Subscribe To Our Newsletter & Stay Updated
